AI in Patient Engagement Market Trends

  • Report ID: 6624
  • Published Date: Aug 14, 2025
  • Report Format: PDF, PPT

AI in Patient Engagement Market Growth Drivers and Challenges:

Growth Drivers

  • Growing adoption of telemedicine and digital health tools: Telemedicine allows patients to access healthcare services remotely, which is especially important in rural or underserved areas. AI-driven patient engagement tools, such as virtual assistants, chatbots, and automated reminders, enhance the telemedicine experience by providing all-day support and improving patient interactions outside of clinical visits. According to a 2022 survey by RockHealth Inc., stated that telemedicine gained 80% overall acceptance, making it the primary route for prescription treatment and mild illness.

    AI-driven telemedicine systems can monitor patients' vital signs remotely and provide early warnings about potential health issues, ensuring continuous engagement between patients and their providers. Moreover, AI systems analyze large datasets from telemedicine interactions, generating insights that help healthcare providers optimize patient engagement strategies and improve overall outcomes.
  • Rising prevalence of chronic diseases: Chronic conditions such as diabetes, cardiovascular diseases, asthma, and hypertension require continuous monitoring, regular communication with healthcare providers, and proactive management, all of which can be facilitated by AI technologies. For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas, as of 2021, 537 million adults (20-79 years) are living with diabetes, and the number is predicted to rise to 643 million by 2030 and 783 million by 2045. AI is helping healthcare systems implement comprehensive chronic care management (CCM) programs. These programs leverage AI to identify at-risk patients, deliver personalized health interventions, and ensure continuous engagement through automated tools and alerts. AI also helps streamline data collection and reporting, making CCM programs more efficient.
  • Advancements in Natural Language Processing (NLP) and Machine Learning (ML): NLP and MI are pivotal in driving the growth of AI in patient engagement. These technologies are transforming how patients interact with healthcare systems, enhancing the experience and the effectiveness of care delivery. NLP enables AI-driven chatbots and virtual assistants to understand and respond to patient queries conversationally. These tools can handle routine inquiries, provide health education, schedule appointments, and answer questions about medications or treatments.

    Recent advancements in NLP, particularly in understanding context, sentiment, and medical terminology, allow for more sophisticated, human-like interactions, making patients feel more supported and engaged. Apollo Hospitals has expanded its partnership with Google Cloud to put healthcare in the hands of every Indian through Apollo's digital platform, Apollo 24|7. Apollo 24|7 teams collaborated with Google Cloud to develop a Clinical Intelligence Engine (CIE) using Vertex AI and generative AI (gen AI) models. Apollo Hospitals is also looking into the usage of Med-PaLM 2, a Google-developed LLM that can answer medical queries and provide clinical text summaries.
    ML algorithms, combined with NLP, can analyze a patient’s health history, preferences, and real-time data to offer personalized advice and reminders. ML models can recommend medication dosages, and lifestyle changes, or alert patients to potential risks based on their unique health profile. This level of personalization is crucial for maintaining engagement, particularly for patients managing chronic conditions.

Challenges

  • High implantation and integration costs: Implementing AI-powered patient engagement systems often requires significant investment in technology infrastructure, including data integration, software development, and AI model training. For many healthcare providers, especially in resource-constrained settings, the cost of adopting these advanced systems may be prohibitive. Additionally, integrating AI solutions with existing electronic health records (EHR) systems or other healthcare platforms can be technically challenging and costly.
  • Lack of standardization: The lack of standardization in AI algorithms, data formats, and healthcare interoperability can hinder the widespread use of AI in patient engagement. Different healthcare providers use different systems, and integrating AI tools across various platforms without common standards can result in inefficiencies, poor data sharing, and reduced effectiveness of AI solutions.

Base Year

2025

Forecast Period

2026-2035

CAGR

19.4%

Base Year Market Size (2025)

USD 7.86 billion

Forecast Year Market Size (2035)

USD 46.29 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of AI in patient engagement is evaluated at USD 9.23 billion.

AI in Patient Engagement Market size was over USD 7.86 billion in 2025 and is poised to exceed USD 46.29 billion by 2035, growing at over 19.4% CAGR during the forecast period i.e., between 2026-2035.

North America commands a 38.5% share in the AI in Patient Engagement market, driven by the growing demand for personalized healthcare and technological advancements, enhancing patient outcomes through 2026–2035.

Key players in the market include Innovaccer, Inc, EnlivenHealth (a subdivision of Omnicell, Inc.), EmpiRx Health, LLC., IBM, Huma, mPulse Mobile, and AllazoHealth.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos